NERM
BNTX icon

New England Research & Management’s BioNTech BNTX Stock Holding History

New England Research & Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-975
Closed -$266K – 178
2021
Q3 		$266K Buy
+975
New +$310K 0.14% 152

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

New England Research & Management's BNTX Position: Q4 2021 in Review

New England Research & Management sold out of BioNTech (BNTX) in Q4 2021, closing a stake of 975 shares — an estimated $266K sold.

New England Research & Management first reported a position in BNTX in Q3 2021 and held it in 1 quarter. The position peaked at $266K in Q3 2021. 354 funds tracked by Wall St. Rank hold BNTX as of Q4 2021.

  • New England Research & Management reported no remaining BioNTech position as of Q4 2021 after selling out during the quarter.
  • New England Research & Management sold 975 BioNTech shares in Q4 2021, an estimated $266K.
  • New England Research & Management first reported a position in BioNTech in Q3 2021 and held it in 1 quarter.
  • New England Research & Management's BioNTech position peaked at $266K in Q3 2021.
  • 354 funds tracked by Wall St. Rank held BioNTech as of Q4 2021.

Based on New England Research & Management's 13F filing for Q4 2021, filed 5 Jan 2022.